Pfizer Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018
PFIZER · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Pfizer Limited has submitted a routine compliance certificate confirming that its Registrar & Share Transfer Agent, KFin Technologies Limited, properly handled dematerialization requests during Q4 FY26 (January-March 2026). The certificate verifies that all share certificates received from Depository Participants were processed within the required 15-day timeframe. The RTA confirmed it approved/rejected dematerialization requests, verified listed status of dematerialized shares, cancelled mutilated certificates, and updated ownership records to reflect the depository as the registered owner. This is a standard quarterly regulatory filing with no unusual activity reported.
No direct impact on shareholders or stock price. This is a mandatory procedural filing confirming normal dematerialization operations were carried out as per SEBI regulations. Investors can note that share dematerialization processes are running smoothly.